Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Promethazine, Atc N05Cm22 (Exclusively Film-Coated Tablets) For The Period December 1St, 2022 - November 30Th, 2024

DAK-GESUNDHEIT Germany has Released a tender for Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Promethazine, Atc N05Cm22 (Exclusively Film-Coated Tablets) For The Period December 1St, 2022 - November 30Th, 2024 in Pharmaceuticals. The tender was released on Mar 29, 2024.

Country - Germany

Summary - Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Promethazine, Atc N05Cm22 (Exclusively Film-Coated Tablets) For The Period December 1St, 2022 - November 30Th, 2024

Deadline - login to view

MT reference number - 80273701

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 80273701

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With re gard to the relevant legal regulations for the awarding of public contracts, a regular process of active ingredient-related, formal procurement procedures takes place in accordance with the regulations of Part 4 of the GWB by DAK-Gesundheit. For medicinal products to be specified by the bidder in Annex 2 to the contract in relation to the above. Active ingredient, promethazine (exclusively film-coated tablets), ATC N05CM22, DAK-Gesundheit intends

Mt Ref Id - 80273701

Deadline - Nov 30, -0001

Share

Similar Tenders :